The switch from latency to a productive infection in EBV-infected B cells is linked to the expression of two viral sequence-specific DNA-binding transcription factors called EB1 and R. EB1 shares sequence homoiogles with the bZIP family of proteins In the basic region required for specific DNA interaction. Here, we provide evidence that EB1 and R can synergistically activate specific transcription, and that overexpressed, unbound EB1, represses the R-induced transcription ('squelching'). In order to identify the EB1 domains involved in transcriptional activation, transcriptional synergy and transcriptional repression, we performed extensive mutagenesis of the EB1 protein. Results show that five segments (region 1 to region 5), localized at the N-termlnus of EB1 exhibit characteristics of activating domains, since they are required for full transcriptional activity, without obvious role in DNAbinding, or the nuclear localization. Two domains rich in basic amino-aclds are required for the nuclear localization of EB1. One domain is within the basic region B, also necessary for specific and stable interaction between EB1 and its cognate DNA sequences. It is also shown that the 'activation' domain, and more surprisingly the DNA-binding domain of EB1, may interact with a factors), essential for Rinduced activation, and probably required for synergy between EB1 and R.
INTRODUCTION
The Epstein-Barr virus (EBV) is a human herpes virus which infects and immortaJizes peripheral B lymphocytes, resulting in the establishment of a latent infection. In such latently infected B cells, the entire EBV genome is maintained largely as an extrachromosomal circular DNA molecule, and viral expression is restricted to a few genes (1) . In some B cell lines, between 0.5% and 5% of the cells produce virus, and their number can be increased by various chemical agents including the tumor promoter 12-Otetradecanoyl-phorbol 13-acetate (TPA) (2) . The TPA-induced production of virions seems to be linked to the synthesis of the EBV transcription factor EB1 (3; 4; 5; 6), which is encoded by the BZLF1 open reading frame (ORF) ( Figure 1A ). EB1 is expressed from two promoters, PZ and PR , either as a monocistronic mRNA of lkb, or as 3Kb and 4 kb long mRNA generated by alternative splicing. The latter expresses both EB1 and the enhancer factor R ( Figure 1A ) (7) . The PZ promoter responds to TPA, and induction is mediated by an AP-1 site identical to and present in a similar location to one in the c-jun promoter ( Figure 1A ) (8; 9; 10) . Once made, EB1 positively autoregulates promoter PZ through two binding sites (9; 11) , and activates the promoter PR controlling the expression of the bicistronic mRNA ( Figure 1A ) (12; 13; 14; 15) . Then, EB1 and R activate the EBV early promoters and the origins of replication, ORIlyt, which are active only during the lytic cycle of the virus (16) .
EB1 was originally described (17) , as being related to the bZTP family of proteins ( Figure 1B) (18) . Significant homology is observed in the domain rich in basic amino acids that is thought to directly contact the DNA in this class of proteins (19) . This domain has been proposed to consist of two clusters, basic region A (BR-A) and basic region B (BR-B), separated by a spacer of alanines ( Figure 1B) (18) . These clusters are similar among all the bZIP proteins and are also conserved in EB1 ( Figure IB) . However, the stable interaction of the bZIP proteins with their cognate DNA sequences occurs only when a dimerization domain, a heptad repeat of leucines located immediately Cterminal to the basic domain, is functional ( Figure IB) (19; 20) . The EB1 dimerization domain is not a repeat of leucines ( Figure  IB ), but conforms to the more general requirement for the formation of a coiled coil with the presence of the 4-3 repeat of hydrophobic residues ( Figure IB ) (21; 22; 23; 24) . Therefore, the DNA-binding domain of EB1 (basic plus dimerization regions), is likely to be restricted to the C-terminal part of the protein, while the N-terminal part of the protein may contain the transcriptional 'activating' domain (25) . However, the precise location of the domains required for transcriptional activation, have not been mapped by detailed mutagenesis of the EB1 protein. Likewise, the nuclear localization and the stability of mutant proteins have not been examined.
Here, it is reported that R and EB1 can activate alone or synergistically specific transcription, and that unbound EB1 inhibits the R-induced activation in a dose-dependent manner. In order to precisely locate the protein domains required for transcriptional activation, synergism, and repression, we generated several deletion, substitution and domain exchange mutants in the EB1 protein. Five N-terminally located segments of EB1 (region 1 to region 5, Figure 3A ) are required for full transcriptional activation, and display properties of 'activation' domains, since they are not required for DNA-binding and nuclear localization. The basic region B of EB1 contains one of the two sequences required for the nuclear localization of the protein, and directs both specific and stable DNA-binding. Using 'domain-swapping' and several other mutants, we also found that region 2 in the activation domain and the basic region B are required for the interaction between EB1 and a factor (s) necessary for R-dependent activation of transcription, and for synergy between EB1 and R.
MATERIALS AND METHODS

Recombinant plasmid constructions
The construction of plasmids pM and pM19 has been described elsewhere (9) . Plasmid p£G was constructed by ligating the double strandedoligonucleotide 5'-CTGCAGCTCGCCTT-CTTTTATCCTCTTTTGTCGACC-3', 5'-TCGAGGTCGAC-AAAAGGATAAAAGAAGGCGAGCTGCAG-3' containing the EBV DR/DL promoter TATA box (map positions 52801 to 52826 on the EBV B95-8 sequence; 26), into plasmid pG2 cut by Xhol and PvuII. Plasmid p/3GR was made by inserting the EBV DR/DL R-responsive enhancer (map positions 53523 to 53593 on the EBV B95-8 sequence; 26) into the Sad site of plasmid p/3G. Plasmid pG221 has been made by ligating the DR promoter proximal sequences (13) into plasmid pG2, and contains four EB1 binding sites: TGTGCAA (ZRED1), TGAGCAA (ZRED2), TGTGTGA (ZRED3) and TGTGTAA (ZRED4) ( Figure 4A ). Each insertion mutant was sequenced before use. The construction of the EB1 expression vector pKSVZ41 and the R expression vector pKSVR have been described elsewhere (7) . Plasmid pSV2/3 expresses a chimeric SV40-/3-globin RNA and was cotransfected as an internal control for transient expression experiments (14).
Construction of EB1 mutants
Plasmid pKSVZ41 containing a cDNA coding for EB1 (7) was cut with restriction enzymes AM, Haein, Hindi Smal and PvuII, in the presence of ethidium bromide so as to produce a maximum of single cut linear molecules (27) . Linear DNA was isolated after agarose gel electrophoresis and ligated directly to 12-bp Bgl II linker oligonucleotides. The insertion location and the number of linkers inserted was determined by sequencing. When necessary, plasmids were extensively digested with Bgl II, religated and sequenced to ensure that only one linker was inserted. Deletion mutants were generated by cutting different insertion mutants with Bgl II, and religating the appropriate DNA fragments to generate in phase internal deletions. Single or multiple amino-acid changes in mutants Z306, Z310 and Z311, as well as exchange of protein domains in mutants ZJ, ZJA and ZJB were performed by using the MUTA-GENE Ml3 in vitro mutagenesis kit from BIO-RAD. All the mutants produced were sequenced before use.
Production of EB1 mutant proteins in vitro
Mutated EB1 cDNAs were subcloned in plasmids pSPT18 or pSPT19 (Boehringer Mannheim). Cloned inserts within the polylinker region were transcribed from either the SP6 or the T7 promoters. The RNA obtained were used to program protein synthesis in messenger-dependent rabbit reticulocyte lysates (Promega) using l4 C-L-Leucine or 35 S-L-Methionine.
Transfection procedure and RNA analysis HeLa cells were grown in DMEM medium supplemented with 10% FCS, and seeded at 10 6 cells per 100 mm Petri dish 4h before transfection. The cells were transfected by the CaPO 4 -DNA precipitate method (28) . Usually, 15 /tg of DNA was added which included: ljig of plasmid pSV2/3 as an internal control for transfection, different amounts of EB1 or R expression vectors and pSVO DNA when required to keep the amount of SV40 early promoter sequences constant, plus pUC18 DNA up to the 15/tg. Cytoplasmic RNAs were extracted as described (14) . Total cytoplasmic RNA (10 to 40/tg) was hybridized overnight at 30°C in 50% formamide, 0.3 M Na Cl, 0.01M Tris-HCl, pH 7.4, to 5'- 
Immunoblots
The 5X10 6 HeLa cells were collected 72h following the transfection, and lysed by Nonidet P-40. Nuclei were separated from cytoplasm by centrifugation. Each subcellular fraction was resuspended in SDS reducing buffer (O.O5M Tris-HCL (pH 6.8), 10% Glycerol, 0.1% SDS, 0.14M /3-mercaptoethanol, O.O5% bromophenol blue), and boiled for 2 min. One third of each extract was electrophoresed on SDS-PAGE and transferred to a nitrocellulose filter before incubation with human anti-EBl antibody.
RESULTS
R and EB1 act synergistically to activate transcription
Transcriptional activation by each or by both of the transcription factors EB1 and R, was investigated by HeLa cells cotransfection of the corresponding expression vectors together with a plasmid carrying the EBV early promoter PM, linked to the mRNAcoding element of the rabbit /3-globin gene. Promoter PM contains an EB1-responsive element superimposed with a . Therefore EBl and R appeared to act synergistically, since their combined effect (37 fold), was more than additive (11.9 fold), as quantitated by counting the radioactivity in the SI protected DNA fragments corresponding to specifically initiated RNA. Using a reporter gene composed of three synthetic double stranded oligonucleotides containing the TATA box, the AP-1 site and the R-binding site of the EBV early promoter PM, respectively.we obtained similar results, indicating that synergism requires only these three promoter elements (not shown).
In all the transfections described here, 0.5/xg of plasmid DNA pSV2/3 with the SV40 early promoter directing the expression of an SV40-/3-globin chimeric RNA, was included as an internal control. This was also done to evaluate the activity of the SV40 early promoter which is employed for the expression of EBl and R. In addition, the amount of SV40 early promoter was kept constant in every transfection by adding, when required, plasmid pSVO containing only the SV40 early promoter sequences. A comparable amount of specifically initiated SV40-j9-globin transcripts (labelled SV) was found in each transfection presented, suggesting that the results of SI nuclease mapping could be compared quantitatively. 18) . In all transfections presented, SI analysis of SV40 early RNAs (SV) expressed from plasmid pSV20 cotransfected as an internal control is presented (lower panel in Figure 2B , 2D and lanes 1 to 9 in figure 2C ). & represents specifically initiated /3-globin RNAs.
EBl represses the R-induced activation
EBl and R can act synergistically, and this effect could reflect either direct interaction between these factors or indirect interaction through an intermediary factor (s). In the latter case, overexpression of unbound EBl should repress the R-induced activation ('squelching' (31)). To test this possibility, we first constructed a minimum promoter containing a TATA box and two R-binding sites, located 5' to the rabbit /3-globin gene ( Figure  2A , p^GR). This promoter had a weak basal activity ( Figure  2C , lane 1), and did not detectably respond to increasing amounts of EBl ( Figure 2C, lanes 2 and 3) . This promoter was activated by R, and the activation increased with increasing amounts of R ( Figure 2C, lanes 4 and 7) . As expected, when increasing amounts of EBl were expressed together with R, EBl repressed the R-dependent activation. The repression was seen both at low ( Figure 2C , lanes 5 and 6) and at high R concentration ( Figure 2C, lanes 8 and 9) . As monitored by immunoblotting, the amount of EBl or R proteins increased following transfection of increasing amounts of expression vector (not shown). It should also be noted that transcription from the SV40 early promoter cotransfected as an internal control, was not affected by cotransfection of the competitor expression vector at all concentrations used, indicating that the factor(s) sequestered by EBl was not required for SV40 early transcription.
We also investigated whether high R concentrations could affect EBl activation of the promoter PM carrying only the API site and no R-responsive enhancer (Mutant PM19, Figure 2A) . Promoter PM19 had a barely detectable basal activity in HeLa cells ( Figure 2D , lane 10), but its activity was detectably increased by high amounts of EBl ( Figure 2D , compare lanes 10, 13 and 16). Although no low affinity R-binding sites could be detected on promoter PM19 (not shown), increasing amounts of R weakly increased the basal activity of promoter PM19 ( Figure 2D , lanes 11 and 12). However, not only there was no synergy between EBl and R, but increasing amounts of R did not repress the EBl-induced activation of promoter PM19, either at low EBl concentration ( Figure 2D , lanes 14 and 15) or at high EBl concentration ( Figure 2D , lanes 17 and 18). In conclusion, since repression of R activation was better seen at high EBl concentrations, and in the absence of an EBl DNA-binding site, it appears to be related to 'squelching' (31).
Construction of EBl mutants
To examine the structural features of EBl directing transcriptional activation, as well as synergy with, and repression of R-induced transcription, deletion, substitution, insertion, and domain exchange mutants were constructed ( Figure 3A and 3C) . Mutant Z59 has an insertion of four amino-acids EDLP at position 59. Some of the mutant proteins were expressed in vitro in the rabbit reticulocyte lysate, and used to analyse their DNA-binding activity. Proteins were labelled with 14 C-leucine or 35 Smethionine and visualised by SDS-PAGE and autoradiography. Equimolar amounts of proteins were incubated at 20°C or 4°C with an excess of 32 P-radiolabelled DNA oligonucleotides, to evaluate the relative affinity of the mutants for the different DNA binding sites in vitro. The transactivation capacity of mutated proteins, alone or in synergy with R, as well as the inhibitory effect of these proteins on the R-dependent transcriptional activation were analysed by transient expression in HeLa cells.
First, the subcellular localization of EBl and of mutated EBl proteins was determined by SDS-PAGE and immunoblotting, after transfection in HeLa cells, and separation of the nuclear fraction from the cytoplasmic fraction ( Figure 3B and 3D) . The wild type protein EBl was found predominantly in the nuclear fraction. Ten mutants, Z2.25, Z25.42, Z42.59, Z59.93, Z93.132, Z132.140.ZA, Z311, ZJ and ZJA were found in majority in the nuclear fraction. The western blot also shows that a comparable amount of the proteins localized in the nucleus was detected by the antibody, indicating that EBl mutants have comparable stability in HeLa cells. On the contrary, mutants Z140.165, Z93.165, Z42.165, Z306, Z310 and ZJB were found mostly in the cytoplasmic fraction. These results were confirmed by indirect immunofluorescence after transfection in Cos-7 and Hela cells of the relevant mutants (not shown). These results also suggest that EBl has two sequences required for the nuclear localization. One contains the sequence RKCRAKFK which overlaps with basic region B, while the second one, located between amino-acid 140 and 165, encompasses the sequence RRTRKP.
Region 2 in the EBl 'activation' domain is essential for synergistic activity with the enhancer factor R
We next tested the ability of various deletion mutants localized in the nucleus, to activate transcription from the EBV early promoter DR ( Figure 4A, plasmid pG221) . Two mutants localized in the cytoplasm, Z140.165 and Z93.165 ( Figure 3A) , were also used as negative controls. As expected, these mutants, gave negative results in transcriptional activity as compared with EBl ( Figure 4B, lanes 9 and 10) . The variants localized in the nucleus allowed us to identify in the N-terminal region of EBl, a set of segments that contributed differently to the EBl transcriptional activation. These segments have been arbitrarily defined region 1 to region 5 ( Figure 3A) . As compared to EBl In an attempt to further study the region encompassing aminoacids 25 to 42, we generated mutants Z25.29 and Z29.42 ( Figure   3A ). Their activity alone and together with R was compared with EBl and with mutant Z25.42. Mutants Z25.29 and Z29.42 localized in the nucleus, and were stably expressed at a level comparable to wild type EBl (not shown). We also used higher amounts of EBl mutants and R proteins in an attempt to vizualized a residual activation potential of the mutants. Deletion of amino-acids 25 to 29 reduced the activity of the mutated protein ( Figure 4C, lanes 4 and 5) , but did not alter its synergistic effect with R ( Figure 4C, lanes 15 and 16) , as compared to that observed with R plus EBl ( Figure 4C, lanes 13 and 14) . Deletion of amino-acids 29 to 42 decreased further the activity of the mutated protein ( Figure 4C, lanes 6 and 7) , but again did not impair its synergistic effect with R ( Figure 4C, lanes 17 and 18) . As already shown, complete inactivation ( Figure 4C , lanes 8 and 9) and loss of synergy ( Figure 4C, lanes 19 and 20) were only observed when amino-acids 25 to 42 were deleted. Two copies of region 25.42 gave ZA a higher transactivation potential ( Figure  4C, lanes 10 and 11) as compared to EBl ( Figure 4C , lane 2 and 3), and synergism between ZA and R was still detected ( Figure 4C, lanes 21 and 22) . In conclusion, an EBl region essential for the activation and for synergy with R, is probably located in or overlaps amino-acids 25 to 42, but additional regions (1, 3, 4 and 5) are also important for the activation process, although not essential for synergy.
Repression, by EBl, of R-dependent transcription, also requires region 2 in the 'activation' domain
The observation that unbound EBl can repress, in a dose dependent manner, the R-dependent transcription ( Figure 2C Figure 3 . SV denotes SV40 specifically initiated RNAs expressed from plasmid pSV2/3 transfected as an internal control, p represents the /3-globin specific transcripts.
suggests that EBl interacts with a factor(s) in a non productive manner. We were interested in determining which region(s) of EBl is essential for its inhibitory effect on R. We therefore examined the repression capacity of the different N-terminal EBl mutants localized in the nucleus. R-dependent activation of promoter p/3GR was repressed by wild type EBl ( Figure 5A , lane 3). Deletion of region 2 (amino-acids 2 to 25), strongly impaired the repression potential of EBl ( Figure 5A, lane 5) . Among the other mutated nuclear proteins examined, only deletion of region 5 (amino-acids 93 to 132), altered the repression competence of EBl ( Figure 5A, lane 8 ) . However, deletion of regions 1, 3 and 4 ( Figure 5A, lanes 4, 6 and 7) , did not modify the repression competence of EBl. As expected, mutants not localized in the nuclei ( Figure 5A , lanes 10 and 11) had no effect on the R-dependent activation. Additional mutants were examined in a second series of experiment ( Figure 5B ), in which we included for comparative purpose, EBl and mutants Z25.42 and Z93.132, already examined in Figure 5A . In mutants Z25. 29 
Transcriptional interference between EBl and R requires the EBl basic domain
As shown above, it seems that region 2 ( Figure 3A) is essential for both activation, synergy and repression, while region 5 is only essential for repression. However, it cannot be ruled out that EB 1 sequences located in the C-terminus are also important for these activities. Extensive mutagenesis in this region is difficult to perform without impairing nuclear localization, or dimerization, and alter the stability of the protein variants (not shown). To study the role of sequences within the C-terminus of EB 1, we constructed EB 1 mutants carrying the Jun basic region A and B (mutant ZJ), the Jun basic region A (mutant ZJA), or the Jun alanine spacer plus region B (mutant ZJB)( Figure 3C ). Since, activation and synergy are tested on promoter pM, where EBl binds to the AP-1 site TGACTCA, we examined the binding of EBl, ZJ, ZJA and ZJB on the AP-1 site (probe Pmo), as compared to other DNA sequences where EBl DNA-binding ability is different (probes DR1, DR2, DR3 and DR4).
First the binding of in vitro expressed EBl and ZJ proteins, was performed at 20 c C or 4°C ( Figure 6A ). When binding was done at 20°C, EBl bound to the four DNA probes Pmo, DR1, DR2 and DR4 with different affinities ( Figure 6B , lanes 1 to 6) but binding of ZJ to the five DNA probes was almost undetectable ( Figure 6B, lanes 7 to 11) . At 4°C, EBl bound to probes Pmo, DR1, DR2, and DR4 with almost equal affinities ( Figure 6B,  lanes 13, 14, 15 and 17) , very poorly to probe DR3 (lane 16), and ZJ bound only to probe Pmo ( Figure 6B, lane 18) . In summary, the Jun basic region in EBl allowed mutant ZJ to bind only to the AP-1 site TGACTCA and the binding was detectable only at 4°C.
To further define which regions of the Jun and EBl basic domains carry the DNA binding specificity, we compared EBl, ZJ, ZJA and ZJB variants for their ability to bind in vitro, either at 20°C or at 4°C, to the AP-1 site TGACTCA and to the specific or at 4°C, with the proteins and the probes described at the top of the panels. In C, the specific complexes were labelled with black squares. F, represents free probe, B represents protein-bound probe and NS represents non-specific complexes. D) S1 nuclcasc analysis (/9) of RNAs extracted from HeLa cells transfected with the reporter gene pM (lanes 1 to 8) , or with the reporter gene p|9GR (lanes 9 to 18). Reporter gene pM was transfected alone (lane 1), or in the presence of EBl (lane 2), or together with the EBl mutants presented in the upper part of the panel (lanes 3 and 4) , or with R (lane 5), or with R plus EBl (lane 6), or with R plus EBl mutant proteins (lanes 7 and 8). The reporter gene p(3GR was transfected with an R-expression vector (lanes 9 and 10), or with an R-expression vector plus two concentrations of competitor protein-expression vectors as presented in the upper part of the pannel. SI nuclease analysis of RNAs expressed from plasmid pSV20 cotransfected as an internal control is also presented (SV).
EBl site DR1 ( Figure 6C) . As vizualized by mobility shift assay, complex formation on the AP-1 site was detected at 20°C with EBl, ZJA and ZJB ( Figure 6C, lanes 1, 3 and 4 ), but not with ZJ (lane 2). Complex formation was also detected at 20°C on the EBl site DR1, but only with EBl and ZJA ( Figure 6C, lanes  5 and 7) . The same assays performed at 4°C show that complex formation was detected on the AP-1 site with proteins EBl, ZJ, ZJA and ZJB ( Figure 6C, lanes 10, 11, 12 and 13 ). Finally complex formation on the EBl site DR1 was only detected at 4°C with EBl and ZJA ( Figure 6C, lanes 15 and 17) . In conclusion, the Jun basic region A in EBl allowed mutant ZJA to bind to the AP-1 site and the DR1 site at both 20 and 4°C, as does EBl, but with a reduced affinity as compared to EBl. However, mutant ZJB bound only to the AP-1 site, and the binding was about ten times more efficient at 4°C than at 20°C, as with mutant ZJ, or with the Jun homodimers (not shown).
Although EBl and the nuclear variants ZJ and ZJA did not bind with the same affinity to the AP-1 site, we nevertheless investigated their activation capacity on promoter PM. As shown in Figure 6D , mutant ZJ (lane 3) and ZJA (lane 4) increased the basal activity of promoter PM, similarly to EBl Qane 2). As compared to the EBl-induced activation (lane 2), and the Rinduced activation (lane 5), coexpression of EBl and R (lane 6) or of ZJA and R (lane 8) had a more than multiplicative effect. Conversely, coexpression of ZJ and R (lane 7), had an effect similar to R alone (lane 5). In conclusion, synergism was observed between EBl and R, or ZJA and R, but not between ZJ and R. This could be explained by the reduced affinity of ZJ for the AP-1 site. However, the three proteins EBl, ZJ and ZJA should be able to repress efficiently the R-dependent activation, since they all carry region 2 and region 5 in the activation domain, and since repression does not require a functional DNA-binding domain (mutant Z311, Figure 5B , lane 9). As shown in figure 6D , the R-induced activation of promoter p/3GR (lanes 9 and 10), was efficiendy repressed by EBl (lanes 11 and 12). As expected, a mutant lacking region 2 in the activation domain did not repress efficiently (lanes 13 and 14) . Surprisingly, mutant ZJ did not repress Oanes 15 and 16), although mutant ZJA repressed like EBl (lanes 17 and 18). In conclusion, our results suggest that the basic region, and probably basic region B, is required for EBl to repress the R-dependent activation of transcription. Again, the level of SV40 specific transcription was not affected at the two concentrations of competitor used ( Figure 6D, lanes 9 to 18, lower panel) , indicating that the factor(s) sequestered by EBl is not essential for SV40 early transcription.
DISCUSSION
Our results demonstrate that EBl can act synergistically with the EBV sequence-specific DNA binding enhancer factor R, and that unbound EBl represses the R-induced activation by a mechanism related to 'squelching' (31) . Repression and synergy, require both region 2 in the 'activation' domain and the basic region of EBl, which is also required for nuclear localization and stable specific binding to DNA.
The EBl basic domain B directs the protein to the nucleus, and mediates specific and stable interaction with DNA It has been proposed that DNA binding specificities of GCN4 and C/EBP correlate with the basic region (BR-A, alanine spacer, BR-B) (32) . We show here that binding specificities of EBl-Jun hybrid proteins also correlate with the basic region, since exchange of the EBl basic region for the homologous regions of Jun modified the binding specificity of EBl to that of Jun. Moreover, the low DNA-binding ability of Jun homodimers for the AP-1 site, as compared to the high DNA-binding ability of Jun/Fos heterodimers, is thought to reflect differences in the ability of their leucine zippers to form dimers (33) . However, our results show that the low DNA-binding ability of the EBl-Jun hybrid ZJ for the AP-1 site is seen when the basic region of Jun is located next to a dimerization domain that otherwise allows stable binding of EBl to the AP-1 site ( Figure 5C, lane 2) . We also observed that ZJ and EBl could form stable heterodimers at temperatures over 20°C (not shown). These results suggest that low DNA-binding ability is also an intrinsic property of the jun basic region, and probably basic region B.
The basic region B of EBl, contains also a signal required for nuclear localization with the sequence RKCRAKFK (nls2: nuclear localization signal 2). Single or multiple amino-acid substitutions in this sequence restricted mutants Z3O6, Z310 to the cytoplasm, but also impaired their binding to DNA in vitro (not shown). Therefore mutants Z3O6 and Z310 might be transported to the nucleus but will not stay into the nucleus because they do not bind to DNA (Figure 3 ). However, this is unlikely since mutant Z311 does not bind to DNA (not shown), but is nuclear ( Figure  3 ). Moreover, although mutant ZJB binds to DNA in vitro, the Jun basic region B in mutant ZJB cannot compensate for the loss nls2, since ZJB is found in the cytoplasm. They also suggest that Jun basic region A contains a peptide that can compensate for the loss of nls2. There is a second signal required for the nuclear localization of EBl located between amino-acids 140 and 165. In this region, one sequence rich in basic amino-acids, RRTRKP (nisi), is related to the short amino-acid sequences found in other viral nuclear proteins (34) . At present we do not know the function of nisi and nls2. It could be that one signal is required for transport to the nuclei while the other is required for remaining in the nucleus (35) . Our results have merefore assigned several novel important functions, i.e., nuclear localization, stability of DNA-binding and specificity of DNA-interaction, to a protein domain which was only described as required for specific interaction with cognate DNA sequences, the basic region B.
Activation and synergy
Our deletional mutagenesis studies indicates that the EBl domain localized between amino-acids 2 and 132, contributes to efficient activation of specific initiation of transcription. In this domain, one segment called region 2, is essential for the activation process, while other segments called 1,3,4 and 5 decreased the activation capacity of EBl to different extents. These regions do not play any role in the capacity of EBl to interact specifically as a dimer to DNA (not shown). By these properties, it seems that the Nterminal region of EBl is similar to 'activating' domains identified in other transcription factors (36; 37; 38; 39; 40) . However, it remains to be established if region 1 to region 5 maintain their activating properties when linked individually to an heterologous DNA-binding domain.
The domain required for transcriptional activation has no clear structural features related to transactivation domains of other proteins. It is not enriched in acidic amino-acids (36; 37). However, regions 3, 4 and 5 have a higher content in prolines than region 1 and region 2 (38; 39), and region 4 and region 5 are rich in glutamines (40) . Moreover, none of these regions seems to be able to adopt an ordered protein structure.
Region 2, is essential for EBl-activation of transcription and for synergy between EBl and R. However, exchanging the EBl basic region for the one of Jun (mutant ZJ, Figure 3C ), did not modify the extent of specific initiation of transcription by ZJ as compared to EB1 ( Figure 6D, lanes 2 and 3) , whereas it impaired synergy between EB1 and ZJ ( Figure 6D, lanes 7) . These results suggest that synergy requires functional interactions between EB1 and R, mediated by both the basic region and the 'activating' region 2. These interactions have been indirectly vizualised by transcriptional interference/squelching experiments.
Transcriptional interference
Our results demonstrate that unbound EB1 can function as a potent inhibitor of the R-activated transcription, and this inhibition is seen either in the absence of an EB1 binding site on the reporter gene, or in the absence of a functional DNA-binding domain in the protein (mutant Z311, figure 5B ). This inhibitory effect looks like 'squelching' experiments, in which overexpressed unbound activators, sequester cellular auxiliary factors required by activators to contact the basal transcription apparatus, resulting in repression of activator-induced transcription (31; 41; 42; 43; 44; 45) . Repression by EB1 is also impaired when region 2 is deleted, but surprisingly, it is also impaired by deletion of region 5 and by exchanging the EB1 basic region for the Jun basic region (mutant ZJ). These results indicate that both EB1 's region 2 and basic region contact a factor(s) essential for R-dependent activation, and probably for synergy. The fact that region 5 is dispensable for synergy, but necessary for repression, reflects probably differences in the conformations of bound or unbound EB1 involved in the interaction between EB1 and the factor(s). However, we also observed that unbound R cannot repress EB1-dependent activation of transcription. This data suggests that EB1 and R do not directly contact the same factors. This is not surprising, since it has been reported that distinct classes of transcriptional activating domains may interact with different cellular targets, resulting in non-reciprocal 'squelching' (42; 45) . Therefore, the lack of repression of EB1-activation by R, probably reflects fondamental structural differences between the activation domains of EB1 and R.
In conclusion, our studies suggest that several domains in the EB1 protein are involved in direct interactions with a factor required for R-dependent activation of transcription and for synergy between EB1 and R. Understanding of the complex interactions between EB1 and R awaits purified factors and in vitro reconstituted systems.
